about
A review of the nonpressor and nonantidiuretic actions of the hormone vasopressinProtein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and ureaAn obligatory role for neurotensin in high-fat-diet-induced obesity.High salt intake increases copeptin but salt sensitivity is associated with fluid induced reduction of copeptin in women.Cadmium exposure and incidence of diabetes mellitus--results from the Malmö Diet and Cancer study.Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke.Copeptin is an independent predictor of diabetic heart disease and death.Low water intake and risk for new-onset hyperglycemia.Cystatin C Is Not Causally Related to Coronary Artery DiseaseLow plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study.Basal Plasma Levels of Copeptin are Elevated in Inactive Inflammatory Bowel Disease after Bowel Resection.Dimethylglycine Deficiency and the Development of Diabetes.Serum copeptin as a new biomarker in the early diagnosis of decline in renal function of type 2 diabetes mellitus patientsMetabolic and Kidney Diseases in the Setting of Climate Change, Water Shortage, and Survival FactorsCopeptin, Insulin Resistance, and Risk of Incident Diabetes in Older Men.Role of TCF7L2 risk variant and dietary fibre intake on incident type 2 diabetes.Serum Copeptin, Pentraxin 3, Anti-Mullerian Hormone Levels With Echocardiography and Carotid Artery Intima-Media Thickness in Adolescents With Polycystic Ovary SyndromeCopeptin in patients with heart failure and preserved ejection fraction: a report from the prospective KaRen-study.Genetic vasopressin 1b receptor variance in overweight and diabetes mellitusEffect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial.Total and Differential Leukocyte Counts in Relation to Incidence of Diabetes Mellitus: A Prospective Population-Based Cohort StudyCopeptin under glucagon stimulationPlasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community.Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke: The Northern Manhattan Study.Plasma copeptin levels are inversely associated with intima-media-thickness in men: the population-based KORA F4 study.Acute-phase proteins and incidence of diabetes: a population-based cohort study.Increased copeptin levels in metabolic syndrome from a Romanian population.Copeptin and its potential role in diagnosis and prognosis of various diseases.Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome.Potential deleterious effects of vasopressin in chronic kidney disease and particularly autosomal dominant polycystic kidney disease.Vasopressin: a novel target for the prevention and retardation of kidney disease?Prognostic value of copeptin in patients with acute stroke.Genetics of Type 2 Diabetes: It Matters From Which Parent We Inherit the Risk.Smokeless tobacco (snus) is associated with an increased risk of type 2 diabetes: results from five pooled cohorts.Copeptin level and copeptin response to percutaneous balloon mitral valvuloplasty in mitral stenosis.Copeptin in obese children and adolescents: relationships to body mass index, cortisol and gender.Copeptin concentrations are not elevated in gestational diabetes mellitus.Vasopressin and metabolic disorders: translation from experimental models to clinical use.Diabetes mellitus and elevated copeptin levels in middle age predict low cognitive speed after long-term follow-up.Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
P2860
Q21131156-4865C72F-05C7-415A-A57D-17EF3107CB5DQ28085593-F13BCEAB-0655-41EF-9B45-2222610632F4Q33834492-4365CA52-5F30-4608-8832-4E079B21F4E2Q34488077-D075556E-C437-478A-A773-8CA36C698270Q34505950-666D6AD5-D3BA-4742-A709-89993D00746EQ35136427-5FE48F7B-1245-4B29-9CE6-953E6AA1AE6DQ35433105-E22B0E20-B49F-41D9-9BFA-8DE2FD756131Q35563596-89F564BC-4989-4CE9-AE3E-88F18FAA9709Q35658295-B61FC25C-6C34-4BB0-9C2A-A8B403E50B81Q35744489-5676B719-DA84-48FF-80DB-25B85DB19FCCQ35850091-A56484DE-9164-4C38-87EC-BA260D70E781Q35881734-100C522C-0756-48C7-A140-E93E5A3E8DA0Q35958749-A314A960-1AEE-4E2D-8E7F-34E016431410Q36047669-047E5933-BAB1-48EC-A7AE-8276CBDCCE06Q36060397-CD4D5ECE-281A-46D5-8DDE-6B88C1BE8335Q36208149-DC4FD53F-AB89-4DF8-A868-EB3D40333183Q36223775-5A5062BA-7018-45BC-B386-C64818741A9CQ36258899-48EA0BD6-FE5E-48DB-96B0-DD1574BCB9DBQ36300778-AC3F9F3A-636F-44AA-80EE-81FD87B0BDB7Q36329310-6498E7E9-6137-4B47-9A67-EC6B1F395F7AQ36593267-A6E7A88E-A77C-4940-B7C5-4428488AC5DDQ36778038-4E38A062-C920-4123-87D1-4B5C968D1A8FQ36965316-DB6D2ADC-EC5D-4955-A014-2EBEB49B024BQ37052940-25C91222-13C7-40BA-A3A2-E1101C74578EQ37306950-6B481FD7-D64C-438C-B2B1-412357C1DE5FQ37421253-EB86D82E-02B7-4988-9804-5008ED8ACB06Q37479457-DFC52FBB-5A43-49C5-954C-A080C8E9379AQ37508425-E7AD02DD-49FD-458E-AEE4-6A2EE97DB476Q37716537-D15A64C5-DE54-48AE-8A79-AD2EC372635BQ37892306-2684B2D9-038E-43F0-B026-61640351125DQ38084471-F5FA7D52-DDBF-4BC8-8861-815F1A172B0AQ38417376-D388B63E-C57D-4C7B-8711-769B7B1265E0Q38816589-94F7D122-E0C2-4A03-8F4F-7A4F2489CE3BQ38977509-4EC115B6-2841-4B7F-BE19-5A32EDFE9ADBQ39251625-E4875D59-7A3E-44C9-ACA8-7838CA879098Q39394021-411773D3-313A-4258-B4D5-6565609EAB47Q39418430-7E41BD1C-30CC-44D5-8CAC-1C67E0A4AC08Q39422254-860E6363-DD27-42D6-8089-1C02784511C4Q39476125-3228878E-8E79-43AB-A6A4-37EEB10E86D4Q39625891-80710F39-5F16-431F-B805-302199E86385
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasma copeptin and the risk of diabetes mellitus.
@en
Plasma copeptin and the risk of diabetes mellitus.
@nl
type
label
Plasma copeptin and the risk of diabetes mellitus.
@en
Plasma copeptin and the risk of diabetes mellitus.
@nl
prefLabel
Plasma copeptin and the risk of diabetes mellitus.
@en
Plasma copeptin and the risk of diabetes mellitus.
@nl
P2093
P2860
P50
P1433
P1476
Plasma copeptin and the risk of diabetes mellitus.
@en
P2093
Andreas Bergmann
Bo Hedblad
Göran Berglund
Joachim Struck
Nils G Morgenthaler
Peter Almgren
Peter M Nilsson
Sofia Enhörning
Thomas J Wang
Valeria Lyssenko
P2860
P304
P356
10.1161/CIRCULATIONAHA.109.909663
P407
P577
2010-05-03T00:00:00Z